<?xml version="1.0" encoding="UTF-8"?>
<p>Different mutations were incorporated into the EV-A71 infectious clone plasmid using Q5 high-fidelity DNA polymerase (NEB) PCR site-directed mutagenesis with primers listed in 
 <xref ref-type="supplementary-material" rid="ppat.1007863.s009">S3 Table</xref>. The purified PCR products were treated with T4 polynucleotide kinase, T4 ligase and 
 <italic>Dpn</italic>I (NEB) for 1 hour at room temperature. The ligation mixture was then transformed into 
 <italic>E</italic>. 
 <italic>coli</italic> XL-10 GOLD ultracompetent cells (Agilent Technologies). The plasmids were transfected into RD cells using Lipofectamine LTX (life Technologies) as reported previously [
 <xref rid="ppat.1007863.ref039" ref-type="bibr">39</xref>]. The transfected virus stock (P0) was further propagated in RD to generate P1 stock for all experiments.
</p>
